ImmunityBio, Inc. — Director's Dealing 2015

Jul 28, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-07-27

Reporting Person: GORLIN STEVE (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	455713	Direct
Common Stock	671720	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.2161	2024-03-17	Common Stock (324012)		Direct
Stock Option (right to buy)	$1.7554	2024-12-18	Common Stock (154292)		Direct
Stock Option (right to buy)	$1.9984	2025-02-16	Common Stock (481390)		Direct

Footnotes

F1: Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is December 18, 2014. The option originally covered 100,000 pre 1.8515 for 1 forward split shares.

F2: Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015.